UNSPSC 85921006: Pharmacotherapy for substance abuse treatment, naltrexone

This classification denotes the group of activities that yields a substance abuse treatment intervention or procedure of pharmacotherapy for substance abuse treatment, naltrexonepharmacotherapy for substance abuse treatment, naltrexone. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code HZ94ZZZ

UNSPSC 85921006 Pharmacotherapy for substance abuse treatment, naltrexone (Commodity) does not match the work actually being solicited under it in recent state and local contract opportunities. The code nominally describes pharmaceutical naltrexone products for substance abuse treatment, yet the recent opportunities block contains no naltrexone procurement, no pharmaceutical supply contracts, and no medication-therapy work directly aligned with the code's scope. Instead, the opportunities show speech pathology staffing (Hillsborough County Public Schools, RFP 24127ARFPDST), substance abuse treatment and cognitive interventions for offenders (Harris County Community Supervision & Corrections Department, RFSQ 260267), cellular therapy software platforms (UT Health San Antonio, RFP 74527P07), mental health and behavioral services (San Mateo County, San Bernardino County), occupational and physical therapy staffing, victim advocacy, and recovery housing—none of which constitute naltrexone procurement or pharmacotherapy supply contracting. The source material contains no evidence of recent state or local naltrexone purchasing, pharmaceutical procurement cycles, or medication therapy management solicitations tagged to this code. The code shows little relevant recent activity; the mismatch between the nominal code scope and the actual opportunities block indicates either tagging error by issuing bodies or dormancy in this commodity line among state and local buyers during the current period.

State and local procurement offices do not appear to be actively procuring naltrexone or narrowly specified pharmacotherapy products under this code at present. Business development professionals evaluating substance abuse treatment service opportunities should monitor separate UNSPSC codes covering behavioral health services, clinical staffing, and treatment programs rather than this pharmaceutical commodity code, which remains inactive in the recent opportunities dataset.